MFBTD
BLCM

MB Financial Bank - Trust Department’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

MB Financial Bank - Trust Department’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2
Closed – – 639
2015
Q3 		$0 Buy
+2
New +$367 ﹤0.01% 660

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

MB Financial Bank - Trust Department's BLCM Position: Q4 2015 in Review

MB Financial Bank - Trust Department sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2015, closing a stake of 2 shares.

MB Financial Bank - Trust Department first reported a position in BLCM in Q3 2015 and held it in 1 quarter. The position peaked at $0 in Q3 2015. 81 funds tracked by Wall St. Rank hold BLCM as of Q4 2015.

  • MB Financial Bank - Trust Department reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 2 Bellicum Pharmaceuticals, Inc. shares in Q4 2015.
  • MB Financial Bank - Trust Department first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2015 and held it in 1 quarter.
  • MB Financial Bank - Trust Department's Bellicum Pharmaceuticals, Inc. position peaked at $0 in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2015, filed 7 Jan 2016.